Meg Puleo joined McCann Health in 2018. As an
experienced Account Director, she has led several
successful product launches—both in the United States
and globally. In 2019, McCann Health presented her
with the “No Fear” award for her diligence to in
stepping up to the plate, undaunted, and leading her
team through challenge and change.
With nearly 10 years in the pharmaceutical
marketing industry, Meg has worked across multiple
customer groups—HCP, DTC, and Global. She’s
launched products within a wide range of categories, such as oncology, pain, vaccines, and
most recently rare disease. Prior to McCann Health,
Meg worked at Grey Group, where she played a key
role in the launch of Verzenio—a targeted therapy for
HR+, HER2- metastatic breast cancer.
In her spare time, Meg loves to travel and has a
passion for real estate and interior design. She
purchased her first investment property at the end of
2020, and has been “work from beach”
ever since.